Pharmaceuticals in China
Description
Pharmaceuticals in China
Summary
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Chinese pharmaceuticals market recorded revenues of $156.6 billion in 2024, representing a compound annual growth rate (CAGR) of 6.7% between 2019 and 2024.
- The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $24.5 billion, equivalent to 15.7% of the market's overall value.
- The Chinese pharmaceuticals market witnessed strong growth in 2024, registering an annual growth of 7.9%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts
- What was the size of the China pharmaceuticals market by value in 2024?
- What will be the size of the China pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the China pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up China's pharmaceuticals market?
Table of Contents
43 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Sinopharm Group Co Ltd
- 8.2. Shanghai Pharmaceuticals Holding Co Ltd
- 8.3. CSPC Pharmaceutical Group Ltd
- 8.4. Jiangsu Hengrui Pharmaceuticals Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: China pharmaceuticals market value: $ million, 2019-24
- Table 2: China pharmaceuticals market category segmentation: % share, by value, 2019-24
- Table 3: China pharmaceuticals market category segmentation: $ million, 2019-24
- Table 4: China pharmaceuticals market geography segmentation: $ million, 2024
- Table 5: China pharmaceuticals market value forecast: $ million, 2024-29
- Table 6: Sinopharm Group Co Ltd: Key Facts
- Table 7: Sinopharm Group Co Ltd: Annual Financial Ratios
- Table 8: Sinopharm Group Co Ltd: Key Employees
- Table 9: Shanghai Pharmaceuticals Holding Co Ltd: Key Facts
- Table 10: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
- Table 11: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
- Table 12: CSPC Pharmaceutical Group Ltd: Key Facts
- Table 13: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
- Table 14: CSPC Pharmaceutical Group Ltd: Key Employees
- Table 15: Jiangsu Hengrui Pharmaceuticals Co Ltd: Key Facts
- Table 16: Jiangsu Hengrui Pharmaceuticals Co Ltd: Annual Financial Ratios
- Table 17: Jiangsu Hengrui Pharmaceuticals Co Ltd: Key Employees
- Table 18: China Size of Population (Million), 2020-24
- Table 19: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 20: China GDP (Current Prices, $ Billion), 2020-24
- Table 21: China Inflation, 2020-24
- Table 22: China Consumer Price Index (Absolute), 2020-24
- Table 23: China Exchange Rate, 2019-24
- List of Figures
- Figure 1: China pharmaceuticals market value: $ million, 2019-24
- Figure 2: China pharmaceuticals market category segmentation: $ million, 2019-24
- Figure 3: China pharmaceuticals market geography segmentation: % share, by value, 2024
- Figure 4: China pharmaceuticals market value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the pharmaceuticals market in China, 2024
- Figure 6: Drivers of buyer power in the pharmaceuticals market in China, 2024
- Figure 7: Drivers of supplier power in the pharmaceuticals market in China, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2024
- Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2024
- Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in China, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
